Importantly, unlike previous investigations in melanoma patients treated with BRAFi and MEKi, we conducted a multivariate analysis to assess the independence of IL-8 baseline levels from other well recognized prognostic factors for PFS and OS. Here, CXCL8 is linked to melanoma.